Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II clinical trial
Objective: To design a clinical trial to test the concept that the immune system is integral in the progression of Parkinson’s disease (PD) and establish…Efficacy of a 6-week brisk walking program in improving non-motor symptoms in people with Parkinson disease – a randomized controlled trial
Objective: To examine whether the brisk walking program would be effective in alleviating non-motor symptoms, and improving sleep quality and health-related quality-of-life (HRQoL) in people…RESPONDING TO COVID-19: THE “ALMEIDA-SANG EQUATION” TO PREDICT TOTAL DISEASE SEVERITY IN PARKINSON’S
Objective: To predict total disease severity in Parkinson’s disease (PD) for online assessments. Background: Assessment (and hence management) of PD has largely been affected by…The early post-transplant period in Parkinson’s disease: the low intravenous dose effect.
Objective: To compare the early results of the introduction of MSCs via different routs of administration on the dynamics of the motor symptoms in patients…Evaluating a Novel Home-Based Care Pathway for People with Parkinson’s Disease
Objective: To evaluate the acceptability, feasibility, safety and effectiveness of a novel remotely delivered Parkinson’s care pathway. Background: Current care pathways for people with Parkinson’s…A French national multicentric prospective study of the 1-year impact of STN-DBS on speech in Parkinson’s disease: profile of progression and prognostic factors.
Objective: 1) To describe the evolution of speech in a large cohort of patients before and 1 year after STN-DBS. 2) To search for preoperative…The Transcriptome from Multiple Regions of the MPTP-induced Parkinson’s disease Mouse Brain after exercise
Objective: To illuminate the respective functions of substantia nigra, striatum, cortex and cerebellum in Parkinson's motor improvement following exercise training in a chronic MPD (MPTP…To Prescribe or Not to Prescribe: The impact of Parkinson’s nurse prescribers
Objective: After formal training, Parkinson’s Nurse Specialists (PNS) can act as independent and supplementary prescribers and initiate/titrate medication. This paper will discuss the impact of…Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database
Objective: To describe the development and organization of the Consortium for Global Diversity in Parkinson’s Disease (CDG-PD), created in 2020 with a broad aim to…Sleep disorders and future diagnosis of parkinsonism: a prospective study using the Canadian Longitudinal Study on Aging
Objective: To determine whether symptoms of insomnia, somnolence, apnea, and restless legs syndrome predict the diagnosis of parkinsonism after three years of follow-up. Background: Earlier…
- « Previous Page
- 1
- …
- 388
- 389
- 390
- 391
- 392
- …
- 436
- Next Page »